About Imatib Tablets
Experience the trending Imatib Tablets-your first-class solution in leukemia management. Designed for valuable impact, Imatib offers incomparable efficacy against chronic myeloid leukemia and other adult blood cancers. Each light yellow, round tablet contains 400 mg of Imatinib Mesylate, a renowned anti-cancer agent, and is prescribed exclusively for adults. Marketed by Cipla Healthcare, these solid tablets come in blister packs with ten tablets per strip, ensuring maximum value and convenience. Try now and experience the value of a prescription-based, allopathic treatment, doctor-recommended for optimal results.
Imatib Tablets: Advanced Leukemia Treatment Solution
Used for chronic myeloid leukemia and various adult blood cancers, Imatib Tablets stand out with their robust, first-class formulation. With Imatinib Mesylate as the active salt, these light yellow, round tablets provide incomparably valuable relief under professional supervision. The oral route ensures easy administration for adults. The anti-cancer efficacy, combined with prescription-based usage and dosage strictly as directed by a physician, makes Imatib the go-to choice for quality and safety-conscious individuals.
Packaging, Samples, and Export Excellence
Imatib Tablets are securely packaged in convenient blister packs, each containing ten tablets, with 100 tablets per box for valuable bulk exchange. Exporters, suppliers, and traders across India can request quotations or sample rates to facilitate global reach. With stable packaging and a 24-month life span, Imatib Tablets maintain integrity during shipment, making them preferred in major export markets. Exchange your requirements and receive a quotation for flexible, first-class supply solutions today.
FAQ's of Imatib Tablets:
Q: How should Imatib Tablets be taken for best results?
A: Imatib Tablets must be taken orally with water, following the exact dosage and schedule prescribed by your physician for safe and effective treatment.
Q: What is the main benefit of using Imatib 400 mg for leukemia?
A: The main benefit is its targeted anti-cancer action using Imatinib Mesylate, which helps control certain types of blood cancer, notably chronic myeloid leukemia, in adults.
Q: When is it recommended to use Imatib Tablets?
A: Imatib Tablets are recommended for adult patients diagnosed with chronic myeloid leukemia or other eligible blood cancers, as advised by a healthcare professional.
Q: Where are Imatib Tablets manufactured and who markets them?
A: These tablets are manufactured and marketed in India by Cipla Healthcare, a trusted name in cancer medication.
Q: What packaging options and export rates are available for Imatib Tablets?
A: Imatib is available in blister packs of ten tablets, with boxes containing 100 tablets. Exporters and traders can request quotations and sample rates for international supply needs.